Related Experiment Video

Updated: Jul 5, 2025

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

3.9K

Optimizing Access to Liquid Biopsy in the Present and Future Cancer Landscape

Arielle J Medford1,2,3, Leif W Ellisen1,2,4

  • 1Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.

JCO Precision Oncology
|January 25, 2024
PubMed
Abstract

None:

We discuss a recent manuscript providing recommendations to improve use and access for liquid biopsy in oncology.

More Related Videos

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.0K

Related Experiment Videos

Last Updated: Jul 5, 2025

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

3.9K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.0K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

Articles linked to this work by shared authors, journal, and citation graph.

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.

Proceedings of the National Academy of Sciences of the United States of America·2026

Current landscape of sequencing ADCs in metastatic breast cancer.

Therapeutic advances in medical oncology·2025

CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance.

Oncogene·2025

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).

NPJ breast cancer·2025

TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Deficits of Molecular Prognosis/Diagnosis Studies in Underserved Populations.

JCO oncology practice·2024

Breast Neuroendocrine Carcinoma: Molecular Insights Beyond Histology.

JCO precision oncology·2026

Beyond the P Value: A Systematic Framework for Interpreting Oncology Clinical Trials.

JCO precision oncology·2026

Performance and Clinical Benefit of Comprehensive Genomic Profiling of GI Tumors in a Comprehensive Cancer Center.

JCO precision oncology·2026

Integrated Methylation and Copy Number Analysis for Noninvasive Bladder Cancer Detection in Urine.

JCO precision oncology·2026

Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay.

JCO precision oncology·2026

DPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study.

JCO precision oncology·2026

Case Reports of Four Patients with HPV-Positive Head and Neck Cancer of Non-Oropharyngeal Origin Undergoing Liquid Biopsy for Circulating Cell-Free HPV-DNA before, during, and after Treatment.

Case reports in oncology·2026

Unequal access to liquid biopsy in colorectal cancer care: a cross-sectional survey of clinicians across hospital tiers in Zhejiang, China.

Frontiers in cell and developmental biology·2026

Comparison of 4 ml of 1% Lignocaine Versus 2 ml of 2% Lignocaine for Landmark-Guided Superior Laryngeal Nerve Block During Awake Fiberoptic Intubation.

Cureus·2026

Immediate In Vivo Human Skin Responses to Picosecond Laser Irradiation: A Histological, Ultrastructural, and Theoretical Study.

Lasers in surgery and medicine·2026

Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Negative autofluorescence in benign exophytic lesions highly suspicious for malignancy: importance of the tool as a rapid screening method for lesions requiring biopsy.

Photodiagnosis and photodynamic therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us